Healthcare provider profile · identity verified

Cassandra Rabago-Reyes, M.D

Internal Medicine · TAMPA, FL · NPI 1487967972

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	443	78
Eliquis	Apixaban	438	50
Gabapentin	Gabapentin	341	62
Furosemide	Furosemide	231	49
Amlodipine Besylate	Amlodipine Besylate	210	41
Metoprolol Tartrate	Metoprolol Tartrate	205	37
Levothyroxine Sodium	Levothyroxine Sodium	173	32
Pantoprazole Sodium	Pantoprazole Sodium	172	50
Potassium Chloride	Potassium Chloride	126	28
Hydralazine Hcl	Hydralazine Hcl	118	29
Donepezil Hcl	Donepezil Hcl	115	21
Baclofen	Baclofen	111	15
Losartan Potassium	Losartan Potassium	109	25
Metoprolol Succinate	Metoprolol Succinate	104	24
Clopidogrel	Clopidogrel Bisulfate	102	19
Levetiracetam	Levetiracetam	100	15
Trazodone Hcl	Trazodone Hcl	97	26
Tamsulosin Hcl	Tamsulosin Hcl	96	25
Warfarin Sodium	Warfarin Sodium	95	suppressed
Jardiance	Empagliflozin	94	12
Lisinopril	Lisinopril	91	26
Carvedilol	Carvedilol	90	16
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	85	15
Nifedipine Er	Nifedipine	79	17
Metformin Hcl	Metformin Hcl	78	17
Duloxetine Hcl	Duloxetine Hcl	72	20
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	71	27
Bumetanide	Bumetanide	69	15
Buspirone Hcl	Buspirone Hcl	67	16
Divalproex Sodium	Divalproex Sodium	63	15
Doxycycline Hyclate	Doxycycline Hyclate	63	37
Montelukast Sodium	Montelukast Sodium	56	14
Tramadol Hcl	Tramadol Hcl	52	13
Mirtazapine	Mirtazapine	49	15
Escitalopram Oxalate	Escitalopram Oxalate	48	11
Ondansetron Hcl	Ondansetron Hcl	47	23
Simvastatin	Simvastatin	47	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	46	25
Namzaric	Memantine Hcl/Donepezil Hcl	44	suppressed
Amiodarone Hcl	Amiodarone Hcl	43	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	42	12
Benztropine Mesylate	Benztropine Mesylate	41	suppressed
Sucralfate	Sucralfate	41	suppressed
Allopurinol	Allopurinol	40	suppressed
Ertapenem	Ertapenem Sodium	40	21
Methenamine Hippurate	Methenamine Hippurate	40	suppressed
Sertraline Hcl	Sertraline Hcl	40	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	39	suppressed
Latanoprost	Latanoprost	38	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Diltiazem Hcl	Diltiazem Hcl	35	suppressed
Entresto	Sacubitril/Valsartan	35	suppressed
Novolog Flexpen	Insulin Aspart	35	12
Clonidine Hcl	Clonidine Hcl	34	suppressed
Risperidone	Risperidone	34	suppressed
Tizanidine Hcl	Tizanidine Hcl	34	suppressed
Budesonide	Budesonide	32	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	32	15
Omeprazole	Omeprazole	32	14
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Spironolactone	Spironolactone	32	suppressed
Januvia	Sitagliptin Phosphate	31	suppressed
Prednisone	Prednisone	31	13
Albuterol Sulfate Hfa	Albuterol Sulfate	30	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Midodrine Hcl	Midodrine Hcl	30	12
Carbidopa-Levodopa	Carbidopa/Levodopa	28	suppressed
Lamotrigine	Lamotrigine	28	suppressed
Lorazepam	Lorazepam	28	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Fosfomycin Tromethamine	Fosfomycin Tromethamine	27	13
Insulin Lispro Kwikpen U-100	Insulin Lispro	27	suppressed
Olanzapine	Olanzapine	27	suppressed
Insulin Aspart Flexpen	Insulin Aspart	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	14
Ozempic	Semaglutide	24	suppressed
Incruse Ellipta	Umeclidinium Bromide	23	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	22	suppressed
Lidocaine Hcl	Lidocaine Hcl	22	16
Rosuvastatin Calcium	Rosuvastatin Calcium	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Calcitriol	Calcitriol	21	suppressed
Dapagliflozin	Dapagliflozin Propanediol	21	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Nystatin	Nystatin	21	13
Prazosin Hcl	Prazosin Hcl	21	suppressed
Cefdinir	Cefdinir	20	suppressed
Procrit	Epoetin Alfa	20	suppressed
Sodium Chloride	0.9 % Sodium Chloride	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Santyl	Collagenase Clostridium Hist.	19	11
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	18	suppressed
Sevelamer Hcl	Sevelamer Hcl	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	suppressed
Azithromycin	Azithromycin	17	suppressed
Ceftriaxone	Ceftriaxone Sodium	17	13
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Fluconazole	Fluconazole	16	11
Hydrochlorothiazide	Hydrochlorothiazide	16	suppressed
Insulin Aspart	Insulin Aspart	16	suppressed
Methimazole	Methimazole	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Albuterol Sulfate	Albuterol Sulfate	15	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Oxcarbazepine	Oxcarbazepine	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Pravastatin Sodium	Pravastatin Sodium	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Xifaxan	Rifaximin	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	suppressed
Brilinta	Ticagrelor	13	suppressed
Digoxin	Digoxin	13	suppressed
Finasteride	Finasteride	13	suppressed
Fluticasone Propionate	Fluticasone Propionate	13	suppressed
Glycopyrrolate	Glycopyrrolate	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Lubiprostone	Lubiprostone	12	suppressed
Prednisolone Acetate	Prednisolone Acetate	12	suppressed
Atenolol	Atenolol	11	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Ramelteon	Ramelteon	11	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error